(BTAI) Bioxcel Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Bioxcel Therapeutics | (BTAI) share price targets
Complete technical analysis of Bioxcel Therapeutics (BTAI) by charts plus indicators, forecast predictions and share price targets for Bioxcel Therapeutics (BTAI)
Bioxcel Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-03-31 View latest technical analysis
10 day averaged volume of Bioxcel Therapeutics is 704350
| Date | Daily Closing Price | Open | High | Low | Volume |
| 31 Mon Mar 2025 | 2.03 | 2.05 | 2.06 | 1.76 | 0.327 times |
| 28 Fri Mar 2025 | 2.12 | 2.26 | 2.31 | 2.09 | 0.197 times |
| 24 Mon Mar 2025 | 2.29 | 2.28 | 2.36 | 2.16 | 0.672 times |
| 21 Fri Mar 2025 | 2.33 | 2.33 | 2.50 | 2.30 | 0.68 times |
| 20 Thu Mar 2025 | 2.36 | 2.28 | 2.38 | 2.12 | 0.716 times |
| 19 Wed Mar 2025 | 2.37 | 2.37 | 3.11 | 2.25 | 5.963 times |
| 18 Tue Mar 2025 | 2.20 | 2.19 | 2.26 | 2.04 | 0.338 times |
| 17 Mon Mar 2025 | 2.28 | 2.07 | 2.40 | 2.07 | 0.257 times |
| 14 Fri Mar 2025 | 2.13 | 2.33 | 2.38 | 1.99 | 0.487 times |
| 13 Thu Mar 2025 | 2.25 | 2.33 | 2.42 | 2.16 | 0.291 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 2 as stoploss in an intra day buy trade for a target of 2.47. However, stock will show a bearish move below 2.
Share price targets for Bioxcel Therapeutics (BTAI)
| Target Type | Value |
| Downside Target | 0.16 |
| Downside Target | 0.30 |
| Downside Target | 0.45 |
| Downside Target | 0.56 |
| Downside Target | 0.58 |
| Downside Target | 0.76 |
| Downside Target | 1.76 |
| Downside Target | 1.99 |
| Upside Target | 2.04 |
| Upside Target | 2.36 |
| Upside Target | 3.11 |
| Upside Target | 3.15 |
| Upside Target | 3.85 |
| Upside Target | 6.83 |
Intraday share price targets for Bioxcel Therapeutics (BTAI)
| Target Type | Value |
| Downside Intraday Target | 1.84 |
| Downside Intraday Target | 1.65 |
| Upside Intraday Target | 2.14 |
| Upside Intraday Target | 2.25 |
| Downside Intraday Target | 1.95 |
Weekly technical analysis of Bioxcel Therapeutics (BTAI)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 31 Mon Mar 2025 | 2.03 | 2.05 | 2.06 | 1.76 | 0.376 times |
| 28 Fri Mar 2025 | 2.12 | 2.28 | 2.36 | 2.09 | 0.109 times |
| 21 Fri Mar 2025 | 2.33 | 2.07 | 3.11 | 2.04 | 1.601 times |
| 14 Fri Mar 2025 | 2.13 | 3.27 | 3.85 | 1.99 | 0.021 times |
| 07 Fri Mar 2025 | 3.37 | 2.40 | 6.83 | 2.37 | 1.581 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Bioxcel Therapeutics (BTAI)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 31 Mon Mar 2025 | 2.03 | 2.40 | 6.83 | 1.76 | 1.361 times |
| 28 Fri Feb 2025 | 2.16 | 0.31 | 3.15 | 0.16 | 2.012 times |
| 31 Fri Jan 2025 | 0.33 | 0.38 | 0.58 | 0.30 | 3.592 times |
| 31 Tue Dec 2024 | 0.37 | 0.44 | 0.56 | 0.30 | 1.649 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Bioxcel Therapeutics (BTAI)
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Bioxcel Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Bioxcel Therapeutics in short term but the sell signal is initial and weak.
Bioxcel Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Bioxcel Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Bioxcel Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.32 and Bioxcel Therapeutics (BTAI) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Bioxcel Therapeutics (BTAI) stock. Volume based technical analysis of Bioxcel Therapeutics (BTAI) stock is negative.
Bioxcel Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Bioxcel Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Bioxcel Therapeutics in short term but the sell signal is initial and weak.
Bioxcel Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Bioxcel Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Bioxcel Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.32 and Bioxcel Therapeutics (BTAI) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Bioxcel Therapeutics (BTAI) stock. Volume based technical analysis of Bioxcel Therapeutics (BTAI) stock is negative.
Bioxcel Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.